FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Inclusion Criteria: 1. Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society Classification (CCS) or a positive ischemia study; 2. Single de novo lesion requiring treatment in a major native coronary artery; 3. Target lesion is \<=18mm in length (visual estimate); 4. Target lesion is \>=3.0mm and \<=3.5mm in diameter (visual estimate); 5. Target lesion stenosis is \>50% and \<100% (visual estimate); Exclusion Criteria: 1. A Q-wave or non-Q-wave myocardial infarction within the preceding 72 hours unless the CK and CK-MB enzymes are back to normal; 2. Unprotected left main coronary disease with \>=50% stenosis; 3. Have an ostial target lesion; 4. Angiographic evidence of thrombus within target lesion; 5. Calcified lesions which cannot be successfully predilated; 6. Ejection fraction \<=30%; 7. Target lesion involves bifurcation (either stenosis of both main vessel and major branch or stenosis of just major branch); 8. Totally occluded vessel;